158 related articles for article (PubMed ID: 22863728)
1. Biomarkers for acute GVHD: can we predict the unpredictable?
Chen YB; Cutler CS
Bone Marrow Transplant; 2013 Jun; 48(6):755-60. PubMed ID: 22863728
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses.
Yin F; Battiwalla M; Ito S; Feng X; Chinian F; Melenhorst JJ; Koklanaris E; Sabatino M; Stroncek D; Samsel L; Klotz J; Hensel NF; Robey PG; Barrett AJ
Stem Cells; 2014 May; 32(5):1278-88. PubMed ID: 24452962
[TBL] [Abstract][Full Text] [Related]
4. Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.
Ferrara JL; Harris AC; Greenson JK; Braun TM; Holler E; Teshima T; Levine JE; Choi SW; Huber E; Landfried K; Akashi K; Vander Lugt M; Reddy P; Chin A; Zhang Q; Hanash S; Paczesny S
Blood; 2011 Dec; 118(25):6702-8. PubMed ID: 21979939
[TBL] [Abstract][Full Text] [Related]
5. High throughput sequential ELISA for validation of biomarkers of acute graft-versus-host disease.
Fiema B; Harris AC; Gomez A; Pongtornpipat P; Lamiman K; Vander Lugt MT; Paczesny S
J Vis Exp; 2012 Oct; (68):. PubMed ID: 23149907
[TBL] [Abstract][Full Text] [Related]
6. Have we made progress in the treatment of GVHD?
Harris AC; Levine JE; Ferrara JL
Best Pract Res Clin Haematol; 2012 Dec; 25(4):473-8. PubMed ID: 23200544
[TBL] [Abstract][Full Text] [Related]
7. Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation.
Nomura S; Ishii K; Fujita S; Nakaya A; Satake A; Ito T
Transpl Immunol; 2017 Aug; 43-44():27-32. PubMed ID: 28687251
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.
Zewde MG; Morales G; Gandhi I; Özbek U; Aguayo-Hiraldo P; Ayuk F; Baez J; Chanswangphuwana C; Choe H; DeFilipp Z; Etra A; Grupp S; Hexner EO; Hogan W; Javorniczky NR; Kasikis S; Kitko CL; Kowalyk S; Meedt E; Merli P; Nakamura R; Qayed M; Reshef R; Rösler W; Schechter T; Weber D; Wölfl M; Yanik G; Young R; Levine JE; Ferrara JLM; Chen YB
Transplant Cell Ther; 2021 Dec; 27(12):988.e1-988.e7. PubMed ID: 34474163
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
10. Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis.
Srinivasan R; Daniels J; Fusaro V; Lundqvist A; Killian JK; Geho D; Quezado M; Kleiner D; Rucker S; Espina V; Whiteley G; Liotta L; Petricoin E; Pittaluga S; Hitt B; Barrett AJ; Rosenblatt K; Childs RW
Exp Hematol; 2006 Jun; 34(6):796-801. PubMed ID: 16728285
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for acute and chronic graft-versus-host disease in regulatory T cells.
Ukena SN; Geffers R; Buchholz S; Stadler M; Franzke A
Transpl Immunol; 2012 Dec; 27(4):179-83. PubMed ID: 22889700
[TBL] [Abstract][Full Text] [Related]
12. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD).
Ayyildiz E; Arslan O; Topçuoğlu P; Arat M; Dalva K; Soydan EA; Tol M; Ilhan O
Transfus Apher Sci; 2007 Feb; 36(1):79-85. PubMed ID: 17234454
[TBL] [Abstract][Full Text] [Related]
13. Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)?
Toubai T; Tanaka J; Paczesny S; Shono Y; Reddy P; Imamura M
Curr Stem Cell Res Ther; 2012 May; 7(3):229-39. PubMed ID: 22023620
[TBL] [Abstract][Full Text] [Related]
14. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
15. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
Großekatthöfer M; Güclü ED; Lawitschka A; Matthes-Martin S; Mann G; Minkov M; Peters C; Seidel MG
Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
[TBL] [Abstract][Full Text] [Related]
16. Plasma biomarkers of lower gastrointestinal and liver acute GVHD.
Harris AC; Ferrara JL; Braun TM; Holler E; Teshima T; Levine JE; Choi SW; Landfried K; Akashi K; Vander Lugt M; Couriel DR; Reddy P; Paczesny S
Blood; 2012 Mar; 119(12):2960-3. PubMed ID: 22286196
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive plasma profiling for the characterization of graft-versus-host disease biomarkers.
De Bock M; Beguin Y; Leprince P; Willems E; Baron F; Deroyer C; Seidel L; Cavalier E; de Seny D; Malaise M; Gothot A; Merville MP; Fillet M
Talanta; 2014 Jul; 125():265-75. PubMed ID: 24840443
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease.
Imoto S; Oomoto Y; Murata K; Das H; Murayama T; Kajimoto K; Sugimoto T; Gomyo H; Nakagawa T; Nishimura R; Koizumi T
Int J Hematol; 2000 Jul; 72(1):92-7. PubMed ID: 10979216
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of biomarkers associated with acute and chronic graft versus host disease.
Ahmed SS; Wang XN; Norden J; Pearce K; El-Gezawy E; Atarod S; Hromadnikova I; Collin M; Holler E; Dickinson AM
Bone Marrow Transplant; 2015 Dec; 50(12):1563-71. PubMed ID: 26367225
[TBL] [Abstract][Full Text] [Related]
20. Limited utility of plasma elafin as a biomarker for skin graft-versus-host disease following allogeneic stem cell transplantation.
George L; Mahabal G; Mohanan E; Balasubramanian P; Peter D; Pulimood S; Lakshmi K; Jeyaseelan L; Abraham A; Srivastava A; Mathews V; George B
Clin Exp Dermatol; 2021 Dec; 46(8):1482-1487. PubMed ID: 34081805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
